The Role of miR-138 in Alzheimer's Disease Dendritic Spine Pathology
About the Research Project
Program
Award Type
Pilot
Award Amount
$150,000
Active Dates
April 01, 2010 - September 30, 2012
Grant ID
A2010385
Goals
We will test if dysregulation of the miR-138 controlled pathway contributes to dendritic spine pathology in a murine tauopathy model. We believe this project is highly innovative because if successful, this study will be one of the first to directly link the dysregulation of a miRNA regulated pathway to the in vivo dendritic spine pathology seen in a mouse model of human tauopathy.
Summary
We are going to investigate the role of an important class of regulatory proteins in Alzheimer’s disease. The success of this project may be beneficial to the public in the form of new treatment developments.
Related Grants
Alzheimer's Disease Research
Axons, Synapses, and Myelin: Where Does Alzheimer's Strike First?
Active Dates
July 01, 2026 - June 30, 2029
Principal Investigator
Selene Lomoio, PhD
Current Organization
Icahn School of Medicine at Mount Sinai
Axons, Synapses, and Myelin: Where Does Alzheimer's Strike First?
Active Dates
July 01, 2026 - June 30, 2029
Principal Investigator
Selene Lomoio, PhD
Current Organization
Icahn School of Medicine at Mount Sinai
Alzheimer's Disease Research
"Cognition in a Dish" to Develop New Alzheimer’s Therapies
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Matthias Hebisch, PhD
Current Organization
Massachusetts General Hospital
"Cognition in a Dish" to Develop New Alzheimer’s Therapies
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Matthias Hebisch, PhD
Current Organization
Massachusetts General Hospital
Alzheimer's Disease Research
Why Alzheimer’s Disease Targets Some Cells First: A Clue in the Anterior Hypothalamus
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Gowoon Son, PhD
Current Organization
Mayo Clinic Jacksonville
Why Alzheimer’s Disease Targets Some Cells First: A Clue in the Anterior Hypothalamus
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Gowoon Son, PhD
Current Organization
Mayo Clinic Jacksonville